collaborative efforts being pursued by pharmaceutical companies o manage in the world of pharmacogenomics and individualized medicine
Post a 260- to 350-word response to the following questions as a New Message into the discussion area:
- Drug companies are pursuing collaborative efforts with other companies to manage in the world of pharmacogenomics and individualized medicine.
- What are some examples of these collaborative efforts being pursued by pharmaceutical companies?
- The National Institute of Health is establishing collaborative efforts through the Accelerated Medical Partnership (AMP) program. What is AMP, and how is this working?
Cite at least 1 peer-reviewed, scholarly, or similar reference.
Format your citations according to APA guidelines.